Centenial Surgical Suture Ltd.
BSE: 531380 | Sector: Health care |
NSE: N.A. | ISIN Code: INE405H01018 |
BSE 00:00 | 10 Aug | 54.90 |
1.85 (3.49%) |
OPEN
54.95 |
HIGH
54.95 |
LOW
54.90 |
NSE 05:30 | 01 Jan | Centenial Surgical Suture Ltd |
OPEN | 54.95 |
PREVIOUS CLOSE | 53.05 |
VOLUME | 4 |
52-Week high | 76.00 |
52-Week low | 42.45 |
P/E | 31.92 |
Mkt Cap.(Rs cr) | 20 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Centenial Surgical Suture Ltd. (CENTENIALSURGIC) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 919.35 | 8.85 | 0.97 | 15585.98 |
Dr Reddy's Labs | 4242.40 | 22.05 | 0.52 | 14405.20 |
Cipla | 1038.20 | 8.95 | 0.87 | 13091.79 |
Lupin | 669.70 | 3.65 | 0.55 | 11771.67 |
Aurobindo Pharma | 564.25 | -3.95 | -0.70 | 11287.14 |
Divi's Lab. | 3945.65 | 7.00 | 0.18 | 8879.82 |
Alkem Lab | 2957.55 | -27.85 | -0.93 | 8829.81 |
Zydus Lifesci. | 364.65 | 4.05 | 1.12 | 7981.90 |
Glenmark Pharma. | 375.70 | 3.80 | 1.02 | 7567.93 |
Torrent Pharma. | 1540.90 | -16.35 | -1.05 | 6742.32 |
Apollo Hospitals | 4519.05 | 90.45 | 2.04 | 6098.30 |
Ipca Labs. | 991.85 | -20.25 | -2.00 | 5399.36 |
Alembic Pharma | 652.35 | -11.45 | -1.72 | 5051.44 |
Abbott India | 19608.20 | -684.00 | -3.37 | 4919.27 |
Laurus Labs | 558.70 | 7.90 | 1.43 | 4707.04 |
Gland Pharma | 2307.30 | -18.25 | -0.78 | 4400.71 |
Granules India | 301.65 | -12.30 | -3.92 | 3238.44 |
Glaxosmi. Pharma | 1445.00 | 2.25 | 0.16 | 3217.51 |
Ajanta Pharma | 1272.60 | -2.25 | -0.18 | 3140.64 |
Sanofi India | 6415.05 | -97.45 | -1.50 | 2956.60 |
Quick Links for Centenial Surgical Suture:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices